CORALLINI, Federica
 Distribuzione geografica
Continente #
NA - Nord America 4.748
AS - Asia 2.083
EU - Europa 934
SA - Sud America 273
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 38
OC - Oceania 8
Totale 8.136
Nazione #
US - Stati Uniti d'America 4.671
SG - Singapore 789
CN - Cina 599
VN - Vietnam 226
BR - Brasile 217
UA - Ucraina 190
DE - Germania 161
IT - Italia 148
GB - Regno Unito 147
HK - Hong Kong 135
TR - Turchia 127
FI - Finlandia 62
FR - Francia 60
CA - Canada 49
BD - Bangladesh 42
SE - Svezia 40
RU - Federazione Russa 37
IN - India 36
ZA - Sudafrica 27
JP - Giappone 24
PL - Polonia 24
AR - Argentina 22
IQ - Iraq 19
MX - Messico 18
PK - Pakistan 18
NL - Olanda 12
CZ - Repubblica Ceca 11
ID - Indonesia 11
CO - Colombia 10
ES - Italia 10
EC - Ecuador 9
AE - Emirati Arabi Uniti 7
AU - Australia 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
VE - Venezuela 7
EG - Egitto 6
LT - Lituania 6
MA - Marocco 6
BE - Belgio 5
IR - Iran 5
MY - Malesia 5
RO - Romania 5
CL - Cile 4
IL - Israele 4
JM - Giamaica 4
PH - Filippine 4
DZ - Algeria 3
HR - Croazia 3
KE - Kenya 3
KG - Kirghizistan 3
MD - Moldavia 3
NP - Nepal 3
IE - Irlanda 2
JO - Giordania 2
KR - Corea 2
LY - Libia 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
TH - Thailandia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GP - Guadalupe 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TG - Togo 1
TN - Tunisia 1
TW - Taiwan 1
Totale 8.099
Città #
Fairfield 505
Ashburn 492
Woodbridge 470
Singapore 450
Houston 271
San Jose 270
Seattle 223
Ann Arbor 221
Chandler 211
Jacksonville 210
Cambridge 183
Beijing 173
Wilmington 166
Santa Clara 164
Hong Kong 133
Los Angeles 89
New York 87
Ho Chi Minh City 83
Dallas 80
Nanjing 69
Izmir 66
Hanoi 50
Princeton 47
San Diego 37
Lauterbourg 36
Munich 36
Council Bluffs 35
Boardman 34
Milan 32
Buffalo 26
Shanghai 26
Shenyang 25
São Paulo 24
Nanchang 23
Tokyo 23
Ferrara 21
Orem 20
Warsaw 20
Johannesburg 17
Montreal 16
The Dalles 15
Tianjin 15
Changsha 14
London 14
Chicago 13
Da Nang 13
Falls Church 13
Jinan 13
San Mateo 13
Chennai 12
Poplar 12
Turku 12
Auburn Hills 11
Frankfurt am Main 11
Haiphong 11
Hebei 11
Mexico City 11
Mountain View 11
Zhengzhou 11
San Francisco 10
Atlanta 9
Dearborn 9
Hefei 9
Manchester 9
Stockholm 9
Toronto 9
Brooklyn 8
Falkenstein 8
Helsinki 8
Baghdad 7
Bremen 7
Brno 7
Columbus 7
Moscow 7
Philadelphia 7
Rome 7
Boston 6
Brasília 6
Guangzhou 6
Haikou 6
Ottawa 6
Phoenix 6
Redwood City 6
Rio de Janeiro 6
Vancouver 6
Amsterdam 5
Brussels 5
Bắc Ninh 5
Charlotte 5
Curitiba 5
Denver 5
Des Moines 5
Guarulhos 5
Istanbul 5
Jakarta 5
Kunming 5
Norwalk 5
Paris 5
Porto Alegre 5
Tappahannock 5
Totale 5.666
Nome #
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 263
Antiangiogenic activity of the MDM2 antagonist nutlin-3 250
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 250
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults 246
Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies 229
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 229
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 227
Circulating levels of frizzled-related protein (FRZB) are increased in patients with early rheumatoid arthritis and decrease in response to disease-modifying antirheumatic drugs. 226
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 226
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 221
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 215
Is there any role for tumour necrosis factor related apoptosis inducing ligand–osteoprotegerin (TRAIL–OPG) interaction in rheumatoid arthritis? 212
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 211
Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin 209
Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts 194
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 190
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 188
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 187
Potential role of PKC inhibitors in the treatment of hematological malignancies 184
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors 182
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 179
The tumour necrosis factor-related apoptosis inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker? 171
TRAIL and osteoprotegerin: a role in endothelial physiopathology? 170
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 168
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 163
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction 161
Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction 159
TRAIL, caspases and maturation of normal and leukemic myeloid precursors 154
TNFRSF11B (tumor necrosis factor receptor superfamily, member 11b) 153
An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction 152
The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis 142
Metalloproteinase 2 cleaves in vitro recombinant TRAIL: Potential implications for the decreased serum levels of TRAIL after acute myocardial infarction 139
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 137
Baseline serum concentrations of TRAIL in early rheumatoid arthritis: Relationship with response to disease-modifying antirheumatic drugs 125
Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand 124
Ruolo di trail nella patogenesi del danno neuronale indotto dalla proteina Tat di HIV-1 122
Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo 118
TNF-α modulates the migratory response of mesenchymal stem cells to TRAIL 112
null 102
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro 100
null 97
null 94
null 90
null 89
null 88
null 86
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo 83
null 78
null 74
null 65
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3 57
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL) 45
Totale 8.136
Categoria #
all - tutte 34.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.020


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022522 15 57 56 11 15 26 35 25 14 29 66 173
2022/2023457 40 23 17 49 80 78 25 40 47 7 28 23
2023/2024197 16 26 3 5 11 51 9 13 1 3 3 56
2024/2025988 21 32 66 50 144 72 23 47 216 75 143 99
2025/20262.756 281 99 287 344 394 189 329 118 259 299 107 50
2026/202758 58 0 0 0 0 0 0 0 0 0 0 0
Totale 8.136